Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway

Abstract The kidney flushes out toxic substances and metabolic waste products, and homeostasis is maintained owing to the kidney efforts. Unfortunately, kidney disease is one of the illnesses with a poor prognosis and a high death rate. The current investigation was set out to assess erythropoietin...

Full description

Bibliographic Details
Main Authors: Marawan A. Elbaset, Bassim M. S. A. Mohamed, Shaimaa A. Gad, Sherif M. Afifi, Tuba Esatbeyoglu, Sahar S. Abdelrahman, Hany M. Fayed
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-42210-1
_version_ 1797452667009630208
author Marawan A. Elbaset
Bassim M. S. A. Mohamed
Shaimaa A. Gad
Sherif M. Afifi
Tuba Esatbeyoglu
Sahar S. Abdelrahman
Hany M. Fayed
author_facet Marawan A. Elbaset
Bassim M. S. A. Mohamed
Shaimaa A. Gad
Sherif M. Afifi
Tuba Esatbeyoglu
Sahar S. Abdelrahman
Hany M. Fayed
author_sort Marawan A. Elbaset
collection DOAJ
description Abstract The kidney flushes out toxic substances and metabolic waste products, and homeostasis is maintained owing to the kidney efforts. Unfortunately, kidney disease is one of the illnesses with a poor prognosis and a high death rate. The current investigation was set out to assess erythropoietin (EPO) potential therapeutic benefits against thioacetamide (TAA)-induced kidney injury in rats. EPO treatment improved kidney functions, ameliorated serum urea, creatinine, and malondialdehyde, increased renal levels of reduced glutathione, and slowed the rise of JAK2, STAT5, AMPK, and their phosphorylated forms induced by TAA. EPO treatment also greatly suppressed JAK2, Phosphatidylinositol 3-kinases, and The Protein Kinase R-like ER Kinase gene expressions and mitigated the histopathological alterations brought on by TAA toxicity. EPO antioxidant and anti-inflammatory properties protected TAA-damaged kidneys. EPO regulates AMPK, JAK2/STAT5, and pro-inflammatory mediator synthesis.
first_indexed 2024-03-09T15:11:57Z
format Article
id doaj.art-9ec20c69b95d44a6804b9808b693bf6f
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-09T15:11:57Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-9ec20c69b95d44a6804b9808b693bf6f2023-11-26T13:20:17ZengNature PortfolioScientific Reports2045-23222023-09-0113111210.1038/s41598-023-42210-1Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathwayMarawan A. Elbaset0Bassim M. S. A. Mohamed1Shaimaa A. Gad2Sherif M. Afifi3Tuba Esatbeyoglu4Sahar S. Abdelrahman5Hany M. Fayed6Pharmacology Department, Medical Research and Clinical Studies Institute, National Research CentrePharmacology Department, Medical Research and Clinical Studies Institute, National Research CentrePharmacology Department, Medical Research and Clinical Studies Institute, National Research CentrePharmacognosy Department, Faculty of Pharmacy, University of Sadat CityDepartment of Food Development and Food Quality, Institute of Food Science and Human Nutrition, Gottfried Wilhelm Leibniz University HannoverDepartment of Pathology, Faculty of Veterinary Medicine, Cairo UniversityPharmacology Department, Medical Research and Clinical Studies Institute, National Research CentreAbstract The kidney flushes out toxic substances and metabolic waste products, and homeostasis is maintained owing to the kidney efforts. Unfortunately, kidney disease is one of the illnesses with a poor prognosis and a high death rate. The current investigation was set out to assess erythropoietin (EPO) potential therapeutic benefits against thioacetamide (TAA)-induced kidney injury in rats. EPO treatment improved kidney functions, ameliorated serum urea, creatinine, and malondialdehyde, increased renal levels of reduced glutathione, and slowed the rise of JAK2, STAT5, AMPK, and their phosphorylated forms induced by TAA. EPO treatment also greatly suppressed JAK2, Phosphatidylinositol 3-kinases, and The Protein Kinase R-like ER Kinase gene expressions and mitigated the histopathological alterations brought on by TAA toxicity. EPO antioxidant and anti-inflammatory properties protected TAA-damaged kidneys. EPO regulates AMPK, JAK2/STAT5, and pro-inflammatory mediator synthesis.https://doi.org/10.1038/s41598-023-42210-1
spellingShingle Marawan A. Elbaset
Bassim M. S. A. Mohamed
Shaimaa A. Gad
Sherif M. Afifi
Tuba Esatbeyoglu
Sahar S. Abdelrahman
Hany M. Fayed
Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
Scientific Reports
title Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
title_full Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
title_fullStr Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
title_full_unstemmed Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
title_short Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
title_sort erythropoietin mitigated thioacetamide induced renal injury via jak2 stat5 and ampk pathway
url https://doi.org/10.1038/s41598-023-42210-1
work_keys_str_mv AT marawanaelbaset erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway
AT bassimmsamohamed erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway
AT shaimaaagad erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway
AT sherifmafifi erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway
AT tubaesatbeyoglu erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway
AT saharsabdelrahman erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway
AT hanymfayed erythropoietinmitigatedthioacetamideinducedrenalinjuryviajak2stat5andampkpathway